Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Sondra and Stephen Hardis Endowed Chair in Oncology Research; Director GI Malignancies Program; Vice-Chair (Clinical Services), Taussig Cancer Inst, Cleveland Clinic
Oncology
Dr. Alok A. Khorana, MD
|
|
Give Review
Alok A. Khorana, MD is an expert in the field of Oncology. He researched medicine at Baroda Medical College. He has 15 awards "Sondra and Stephen Hardis Endowed Chair in Oncology Research", "Meliora Award (Team Award(", "Silver Team Award", "Patient- and Family-Centered Care Award", "CMS Meaningful Use Stage 1 Certification", "Internal Medicine Research Mentoring Award, Department of Medicine", "Teacher of the Year", "Fellow", "Cancer Action Grant for Cancer Research", "Dr Robert Cooper Endowed Fund for Clinical Research", "James P. Wilmot Cancer Research Fellowship", "Faculty Award for Creative Excellence", "Amgen Clinical Fellowship Grant", "Gold Medal for Academic Excellence in Pharmacology" and "Dr H. P. Shastry Gold Medal for Academic Excellence; Undergraduate Academy Gold Medal". Alok Khorana is a published doctor and has 74 publications published. The lastest was: 'Prospective Clinical Study of Precision Oncology in Solid Tumors.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
- Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study.
- Venous thromboembolism prophylaxis and treatment in patients with Cancer: american society of clinical oncology clinical practice guideline update 2014.
- Integrating Systemic and Surgical Approaches to Treating Metastatic Colorectal Cancer.
- Prevention of venous thromboembolism in Cancer outpatients: guidance from the SSC of the ISTH: reply.
- Screening high-risk Cancer patients for VTE: A prospective observational study.
- Prevention of VTE in Cancer Outpatients: guidance from the SSC of the ISTH.
- Laparoscopy mitigates adverse oncological effects of delayed adjuvant chemotherapy for colon Cancer.
- Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder Cancer.
- Pattern of Frequent But Nontargeted Pharmacologic Thromboprophylaxis for Hospitalized Patients With Cancer at Academic Medical Centers: A Prospective, Cross-Sectional,...
- Risk Assessment for Thrombosis in Cancer.
- Venous thromboembolism prophylaxis and treatment in patients with Cancer: American Society of Clinical Oncology clinical practice guideline update.
- Targeted prophylaxis in Cancer: the evidence accumulates.
- Incidental venous thromboembolism in oncology patients.
- The use of weighted and scored risk assessment models for venous thromboembolism.
- Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk Cancer patients undergoing chemotherapy in the United States.
- Embolic stroke in a patient with a patent foramen ovale and an indwelling catheter.
- Cancer and coagulation.
- Risk assessment and prophylaxis for VTE in Cancer patients.
- Can literature enhance oncology training? A pilot humanities curriculum.
- The role of thromboprophylaxis in Cancer patients: emerging data.
- Physician as typist.
- Leukocytosis, thrombosis and early mortality in Cancer patients initiating chemotherapy.
- Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergro...
- The role of the oncologist in the management of VTE.
- A computerized prompt for thromboprophylaxis in hospitalized Cancer patients.
- Venous thromboembolism and prognosis in Cancer.
- Emerging risk stratification approaches to Cancer-associated thrombosis: risk factors, biomarkers and a risk score.
- Cancer, clots and consensus: new understanding of an old problem.
- Venous thromboembolism prophylaxis and treatment in Cancer: a consensus statement of major guidelines panels and call to action.
- Assessing risk of venous thromboembolism in the patient with Cancer.
- Cancer and thrombosis: back to the future renewed interest in an old problem.
- Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study.
- New insights into Cancer-associated thrombosis.
- Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
- Blood transfusions, thrombosis, and mortality in hospitalized patients with Cancer.
- Variation in the cost of medications for the treatment of colorectal Cancer.
- Disorientation.
- Development and validation of a predictive model for chemotherapy-associated thrombosis.
- Incidence, risk factors and consequences of portal vein and Systemic thromboses in hepatocellular carcinoma.
- Frequency, risk factors, and trends for venous thromboembolism among hospitalized Cancer patients.
- The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized Cancer patients.
- A meta-analysis and systematic review of the efficacy and safety of anticoagulants as Cancer treatment: impact on survival and bleeding complications.
- Tissue factor expression, angiogenesis, and thrombosis in pancreatic Cancer.
- Approaches to risk-stratifying Cancer patients for venous thromboembolism.
- Thromboembolism in hospitalized neutropenic Cancer patients.
- FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis.
- Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
- Vascular endothelial growth factor and DPC4 predict adjuvant therapy outcomes in resected pancreatic Cancer.
- The influence of host response on colorectal Cancer prognosis.
- Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.
- Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role ...
- Prospective Clinical Study of Precision Oncology in Solid Tumors.
- Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic Cancer.
- A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroEsophageal adenocarcinomas.
- Cancer patients and awareness of venous thromboembolism.
- Risk stratification for Cancer-associated venous thromboembolism.
- American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with Cancer.
- Venous thromboembolism in patients with diffuse large B-cell Lymphoma.
- Pancreatic Cancer and thromboembolic disease.
- Concordance: how does a physician who is neither black nor white decide when race is a factor?
- A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with Malignant melanoma.
- Immunopathogenesis of HIV and HTLV-1 infection: mechanisms for Lymphomagenesis.
- Thromboembolism is a leading cause of death in Cancer patients receiving outpatient chemotherapy.
- Plasma tissue factor may be predictive of venous thromboembolism in pancreatic Cancer.
- Cancer and thrombosis: implications of published guidelines for clinical practice.
- Malignancy, thrombosis and Trousseau: the case for an eponym.
- High rates of symptomatic and incidental thromboembolic events in gastrointestinal Cancer patients.
- Clinical roundtable monograph. The oncologist's role in management of venous thromboembolism.
- Identifying Cancer patients at risk for venous thromboembolism.
- Survival outcomes in Liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
- A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin''s Lymphoma.
- At the end of A day. A young doctor considers an end-of-life decision and the love that informs it.
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Sondra and Stephen Hardis Endowed Chair in Oncology Research
- Meliora Award (Team Award(
- Silver Team Award
- Patient- and Family-Centered Care Award
- CMS Meaningful Use Stage 1 Certification
- Internal Medicine Research Mentoring Award, Department of Medicine
- Teacher of the Year
- Fellow
- Cancer Action Grant for Cancer Research
- Dr Robert Cooper Endowed Fund for Clinical Research
- James P. Wilmot Cancer Research Fellowship
- Faculty Award for Creative Excellence
- Amgen Clinical Fellowship Grant
- Gold Medal for Academic Excellence in Pharmacology
- Dr H. P. Shastry Gold Medal for Academic Excellence; Undergraduate Academy Gold Medal
Education
-
University of Rochester -
University at Buffalo -
Baroda Medical College
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1912926346 | |
| NPPES Provider LastName | KHORANA | |
| NPPES Provider FirstName | ALOK | |
| NPPES Provider ZIPCode | 146420001 | |
| NPPES Provider State | NY | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 32.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1912926346 |
| Last Name Of The Provider | KHORANA |
| First Name Of The Provider | ALOK |
| View All |
Similar Doctors
|
Dr. Joanne C. Mortimer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter J. Oppelt, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Henry B. Koon Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bassam N. Estfan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dale H. Cowan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mikkael A. Sekeres, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ashley E. Rosko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charis E. Eng, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|